Mesothelioma cell heterogeneity identified by single cell RNA sequencing

May 2, 2025 | Comments Off on Mesothelioma cell heterogeneity identified by single cell RNA sequencing

Scientific Reports 2025 March 13 [Link] Licun Wu, Zongjie Wang, Amin Zia, Shana O Kelley, Marc de Perrot Abstract Mesothelioma cell heterogeneity encompasses diverse morphological and molecular characteristics observed within…

Potential advantage of magnetic resonance imaging in detecting thoracic wall infiltration in pleural mesothelioma: A retrospective single-center analysis

May 1, 2025 | Comments Off on Potential advantage of magnetic resonance imaging in detecting thoracic wall infiltration in pleural mesothelioma: A retrospective single-center analysis

JTCVS Open 2024 October 22 [Link] Isabel Barreto, Sabine Franckenberg, Thomas Frauenfelder, Isabelle Opitz, Olivia Lauk Abstract Objectives: Thoracic wall infiltration in pleural mesothelioma determines the extent of resection and…

Clinical Significance of Bone Metastases in Pleural Mesothelioma

April 30, 2025 | Comments Off on Clinical Significance of Bone Metastases in Pleural Mesothelioma

Thoracic Cancer 2025 March [Link] Mitsutomi Miyake, Kozo Kuribayashi, Hiroshi Doi, Aki Kubota, Taiichiro Otuski, Yoshiki Negi, Koji Mikami, Ryo Takahashi, Akifumi Nakamura, Yasuhiro Nakajima, Daichi Fujimoto, Kazuhiro Kitajima, Toshiyuki…

Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma

April 29, 2025 | Comments Off on Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma

Thoracic Cancer 2025 March [Link] Berta Mosleh, Stefan Schwarz, Anna Cho, Katharina Sinn, Ariane Steindl, Sabine Zöchbauer-Müller, Wolfgang J Köstler, Karin Dieckmann, Martin Heilmann, Joachim Widder, Daniela Gompelmann, Clemens Aigner,…

Sarcomatoid pleural mesothelioma evaluated using diffusion-weighted whole-body imaging with background body signal suppression

April 28, 2025 | Comments Off on Sarcomatoid pleural mesothelioma evaluated using diffusion-weighted whole-body imaging with background body signal suppression

Respiratory Investigation 2025 May [Link] Ryosuke Kinoshita, Norihisa Takeda, Hiroko Kiyotoshi, Masahiro Sugihara, Mamiko Kuriyama, Makoto Nakao, Takuji Tsuyuki, Hideki Muramatsu Abstract An 83-year-old man with a history of asbestos…

Development of pH-adjusted NMR methodology for quantitation of caffeoylquinic acid derivatives and evaluation of their antimalignant pleural mesothelioma potential

April 25, 2025 | Comments Off on Development of pH-adjusted NMR methodology for quantitation of caffeoylquinic acid derivatives and evaluation of their antimalignant pleural mesothelioma potential

Journal of Pharmaceutical and Biomedical Analysis 2025 July 15 [Link] Hau Thi Hong Bui, Yoon-Jin Lee, Trung Huy Ngo, Punam Thapa, Yun-Seo Kil, Chang Yeol Lee, Hyukjae Choi, Kyu Joon…

Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma

April 24, 2025 | Comments Off on Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma

Seminars in Nuclear Medicine 2025 March [Link] Manar Badarna, Zohar Keidar, Elite Arnon-Sheleg Abstract Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer characterized by its unique growth patterns,…

FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma

April 23, 2025 | Comments Off on FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma

Communications Biology 2025 February 27 [Link] Eleonora Vecchio, Raffaella Gallo, Selena Mimmi, Debora Gentile, Caterina Giordano, Emilio Straface, Rossana Marino, Carmen Caiazza, Arianna Pastore, Maria Rosaria Ruocco, Alessandro Arcucci, Marco…

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors

April 22, 2025 | Comments Off on Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors

Journal of the American Chemical Society 2025 March 5 [Link] Meng Rui Chang, Egor M Matnurov, Chengnan Wu, Jemma Arakelyan, Ho-Jung Choe, Vladimir Kushnarev, Jian Yu Yap, Xiu Xuan Soo,…

Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)

April 21, 2025 | Comments Off on Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)

International Journal of Oncology 2025 March [Link] Dimitrios Andreikos, Demetrios A Spandidos, Vasiliki Epameinondas Georgakopoulou Abstract Malignant mesothelioma (MM) is a rare but aggressive cancer linked to asbestos exposure and…

Categories